Hera Biotech, Inc. — Form D/A

Hera Biotech, Inc. of SAN ANTONIO, TX, a company, filed a Form D amendment with the SEC on 2022-02-15. The offering totals $2.0M, of which $854K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-02-15
• Form: D/A
• Accession: 0001831293-22-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.0M
• Amount sold: $854K
• Remaining: $1.1M
• Investors: 19
• Date of first sale: 2020-11-03
• Revenue range: Decline to Disclose
• SEC file number: 021-380138

Issuer

• Name: Hera Biotech, Inc.
• CIK: 0001831293
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 4725 COLLEGE PARK, SUITE 200, SAN ANTONIO, TX, 78249
• Phone: 2106831069

Officers, directors & promoters (6)

Other filings by this issuer (5)

More

• CIK 1831293 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search